ImmuPharma (LON:IMM) Stock Price Crosses Below 200 Day Moving Average – Should You Sell?

Shares of ImmuPharma plc (LON:IMM) crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 7.88 and traded as low as GBX 4.48. ImmuPharma shares last traded at GBX 4.54, with a volume of 2,198,334 shares.

ImmuPharma Price Performance

The firm has a market cap of £30.54 million, a price-to-earnings ratio of -5.50 and a beta of 3.02. The firm’s fifty day moving average is GBX 6.45 and its two-hundred day moving average is GBX 7.88.

ImmuPharma Company Profile

ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.